Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 70, 2015 - Issue 2
137
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Masashi Uehara, Yukio Nakamura, Jun Takahashi, Mikio Kamimura, Fumihiro Isobe, Tomomi Yamaguchi, Tomoki Kosho, Shigeharu Uchiyama, Takako Suzuki & Hiroyuki Kato. (2018) Efficacy of denosumab therapy for neurofibromatosis type 1 with osteoporosis and history of fractures: a case report. Therapeutics and Clinical Risk Management 14, pages 1243-1246.
Read now

Articles from other publishers (3)

Mustafa Saleh, AlFadel Dib, Sarah Beaini, Charbel Saad, Sary Faraj, Youssef El Joueid, Yasmine Kotob, Lara Saoudi & Nancy Emmanuel. (2023) Neurofibromatosis type 1 system-based manifestations and treatments: a review. Neurological Sciences 44:6, pages 1931-1947.
Crossref
Maud Jalabert, Salah Ferkal, Jean-Claude Souberbielle, Emilie Sbidian, Arthur Mageau, Florent Eymard, Philippe Le Corvoisier, Laurence Allanore, Xavier Chevalier, Pierre Wolkenstein & Sandra Guignard. (2021) Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France. Calcified Tissue International 108:6, pages 738-745.
Crossref
Jingcheng Wang, Congcong Liu, Cheng Wang, Jing Li, Guohua Lv, Jiancuo A, Youwen Deng & Wenjun Wang. (2019) Early and Midterm Outcomes of Surgical Correction for Severe Dystrophic Cervical Kyphosis in Patients with Neurofibromatosis Type 1: A Retrospective Multicenter Study. World Neurosurgery 127, pages e1190-e1200.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.